Hematologic Cancers
 

Your access to vital information on hematologic cancers is now easier, with comprehensive coverage of this topic at your fingertips. ASCO has gathered and synthesized data on hematologic cancers from a multitude of key sources, including the Journal of Clinical Oncology and other ASCO publications, the Virtual Meeting, and more. Experience the ease of finding in-depth information on hematologic cancers topics, and visit often to remain current with timely updates.

  

 
JCO Highlighted Hematologic Cancers Articles Last Updated: October 20, 2009
High-Dose Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: High Rates of Rapid Cytogenetic and Molecular Responses (JCO, October 2009)
Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma (JCO, October 2009)
Acute Myeloid Leukemia With Translocation (8;21) or Inversion (16) in Elderly Patients Treated With Conventional Chemotherapy: A Collaborative Study of the French CBF-AML Intergroup (JCO, October 2009)
Phase I/II Trial of AEG35156 X-Linked Inhibitor of Apoptosis Protein Antisense Oligonucleotide Combined With Idarubicin and Cytarabine in Patients With Relapsed or Primary Refractory Acute Myeloid Leukemia (JCO, October 2009)
Lenalidomide Plus Prednisone Results in Durable Clinical, Histopathologic, and Molecular Responses in Patients With Myelofibrosis (JCO, October 2009)

More >
Medline Latest Hematologic Cancers Articles Last Updated: November 1, 2009
Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup. (J Clin Oncol, 2009 Aug)
High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses. (J Clin Oncol, 2009 Aug)
Interleukin-12 receptor beta2: from cytokine receptor to gatekeeper gene in human B-cell malignancies. (J Clin Oncol, 2009 Aug)
Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia. (J Clin Oncol, 2009 Aug)
Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma. (J Clin Oncol, 2009 Aug)

More >
Virtual Meeting  

Presentations from the 2008 ASCO Annual Meeting

View hematologic cancers track presentations from the 2008 ASCO Annual Meeting. In addition, search hematologic cancers track presentations from previous meetings.

Leukemia/Myeloma including Transplantation

Oral presentations and discussions from the 2005 Annual Meeting

More >
Abstracts  

Abstracts from the 2008 ASCO Annual Meeting

Search the 2008 hematologic cancers abstracts as well as abstracts back through the 2000 Annual Meeting.

The clinical spectrum of adult acute myeloid leukemia (AML) associated with core binding factor (CBF) translocations

Abstract presented at 2005 Annual Meeting

More >
Educational Book  

Manuscripts from the 2009 Educational Book

Find hematologic cancers manuscripts grouped into areas of interest, or search the 2002-2009 Educational Books archive.

More >
Cancer.Net  

Cancer.Net doctor-approved cancer information from ASCO

Find information and resources to support your patients living with hematologic cancers

More >
 
 
2010 AM
2010 ASCO Annual Meeting
McCormick Place – Chicago, IL
June 4 - 8, 2010

Highlights
This online resource is supported by: